about
siRNA Versus miRNA as Therapeutics for Gene SilencingA semi-supervised tensor regression model for siRNA efficacy prediction.Effective Small Interfering RNA Therapy to Treat CLCN7-dependent Autosomal Dominant Osteopetrosis Type 2.Dextran functionalization enhances nanoparticle-mediated siRNA delivery and silencing.Improved asymmetry prediction for short interfering RNAs.A tumor-targeting cRGD-EGFR siRNA conjugate and its anti-tumor effect on glioblastoma in vitro and in vivo.Terminal Duplex Stability and Nucleotide Identity Differentially Control siRNA Loading and Activity in RNA InterferenceEpigenetics, fragile X syndrome and transcriptional therapy.
P2860
Q26786876-2950F83E-CB98-406E-A736-FF1CA9E55A83Q35233194-403B79E5-AA47-47C3-8C04-41E5E04B0CE0Q36928118-CD1CD092-992A-42DD-B363-129E670AF2F4Q37354206-BEF21C9E-735D-40AF-8207-059881550686Q37584772-0A8C1007-FC5C-4B82-90D2-B47036140A1EQ38717131-A310DF81-7F7C-4392-AC5F-D64FF21E6E93Q41655216-B1975DD2-F7AE-4E18-9D88-2FED7B8D8C91Q54765415-529C4225-4CC2-4B4F-9713-E3428E05E77B
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Design of siRNA Therapeutics from the Molecular Scale
@en
Design of siRNA Therapeutics from the Molecular Scale.
@nl
type
label
Design of siRNA Therapeutics from the Molecular Scale
@en
Design of siRNA Therapeutics from the Molecular Scale.
@nl
prefLabel
Design of siRNA Therapeutics from the Molecular Scale
@en
Design of siRNA Therapeutics from the Molecular Scale.
@nl
P2093
P2860
P356
P1433
P1476
Design of siRNA Therapeutics from the Molecular Scale
@en
P2093
Christina Chan
Daniel Vocelle
Phillip Angart
S Patrick Walton
P2860
P304
P356
10.3390/PH6040440
P577
2013-01-01T00:00:00Z